Title : An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing's Syndrome and Autonomous Cortisol Secretion.

Pub. Date : 2021 Sep 27

PMID : 34143883






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 An open-label phase I/II a clinical trial of 11beta-HSD1 inhibitor for Cushing"s syndrome and autonomous cortisol secretion. Hydrocortisone hydroxysteroid 11-beta dehydrogenase 1 Homo sapiens
2 CONTEXT: 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors demonstrate anti-metabolic and anti-sarcopenic effects in Cushing"s syndrome (CS) and autonomous cortisol secretion (ACS) patients. Hydrocortisone hydroxysteroid 11-beta dehydrogenase 1 Homo sapiens